These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Defective pre-mRNA splicing in PKD1 due to presumed missense and synonymous mutations causing autosomal dominant polycystic disease. Gonzalez-Paredes FJ, Ramos-Trujillo E, Claverie-Martin F. Gene; 2014 Aug 10; 546(2):243-9. PubMed ID: 24907393 [Abstract] [Full Text] [Related]
3. Splicing defects caused by exonic mutations in PKD1 as a new mechanism of pathogenesis in autosomal dominant polycystic kidney disease. Claverie-Martin F, Gonzalez-Paredes FJ, Ramos-Trujillo E. RNA Biol; 2015 Aug 10; 12(4):369-74. PubMed ID: 25757501 [Abstract] [Full Text] [Related]
6. Aberrant PKD2 splicing due to a presumed novel missense mutation in autosomal-dominant polycystic kidney disease. Tan YC, Blumenfeld J, Michaeel A, Donahue S, Balina M, Parker T, Levine D, Rennert H. Clin Genet; 2011 Sep 10; 80(3):287-92. PubMed ID: 20950398 [Abstract] [Full Text] [Related]
7. Mutational analysis in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): Identification of five mutations in the PKD1 gene. Abdelwahed M, Hilbert P, Ahmed A, Mahfoudh H, Bouomrani S, Dey M, Hachicha J, Kamoun H, Keskes-Ammar L, Belguith N. Gene; 2018 Sep 10; 671():28-35. PubMed ID: 29860066 [Abstract] [Full Text] [Related]
9. Novel method for genomic analysis of PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease. Tan YC, Blumenfeld JD, Anghel R, Donahue S, Belenkaya R, Balina M, Parker T, Levine D, Leonard DG, Rennert H. Hum Mutat; 2009 Feb 10; 30(2):264-73. PubMed ID: 18837007 [Abstract] [Full Text] [Related]
10. Aberrant splicing in the PKD2 gene as a cause of polycystic kidney disease. Reynolds DM, Hayashi T, Cai Y, Veldhuisen B, Watnick TJ, Lens XM, Mochizuki T, Qian F, Maeda Y, Li L, Fossdal R, Coto E, Wu G, Breuning MH, Germino GG, Peters DJ, Somlo S. J Am Soc Nephrol; 1999 Nov 10; 10(11):2342-51. PubMed ID: 10541293 [Abstract] [Full Text] [Related]
18. Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients. Torra R, Badenas C, Pérez-Oller L, Luis J, Millán S, Nicolau C, Oppenheimer F, Milà M, Darnell A. Am J Kidney Dis; 2000 Oct 04; 36(4):728-34. PubMed ID: 11007674 [Abstract] [Full Text] [Related]
19. Two silent substitutions in the PDHA1 gene cause exon 5 skipping by disruption of a putative exonic splicing enhancer. Boichard A, Venet L, Naas T, Boutron A, Chevret L, de Baulny HO, De Lonlay P, Legrand A, Nordman P, Brivet M. Mol Genet Metab; 2008 Mar 04; 93(3):323-30. PubMed ID: 18023225 [Abstract] [Full Text] [Related]
20. Prediction of single-nucleotide substitutions that result in exon skipping: identification of a splicing silencer in BRCA1 exon 6. Raponi M, Kralovicova J, Copson E, Divina P, Eccles D, Johnson P, Baralle D, Vorechovsky I. Hum Mutat; 2011 Apr 04; 32(4):436-44. PubMed ID: 21309043 [Abstract] [Full Text] [Related] Page: [Next] [New Search]